Author: Global Cancer Consortium

The company is a specialty biopharmaceutical company that utilizes an immunology-based drug development platform to actualize therapeutics indicated for cancer and autoimmune disease. The company’s …

Read More

The company is a medical devices company that has developed a novel therapeutic technology for the treatment of prostate cancer. The company’s apparatus uses non-invasive MRI imaging to identify prostate cell masses, and a trans-urethral ultrasound applicator …

Read More

The latest issue of the New Companies & Technologies Report (NCTR) has been published on innovative companies and technologies in health and medicine. * If you are not a subscriber to the Intelligence Services and wish to receive full access to all company information listed below please visit: onemedplace.com/nctr. In this issue we profile innovation in the following areas (by keywords): 1. AML Remission Maintenance 2. Monoclonal Antibody Therapeutics 3. Prostate Cancer 4. Nitric Oxide Synthase Inhibitor Therapeutics 5. Hormone Contraceptives

Read More